These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9569038)
1. Evaluation of FHIT gene alterations in ovarian cancer. Buttitta F; Marchetti A; Radi O; Bertacca G; Pellegrini S; Gadducci A; Genazzani AR; Bevilacqua G Br J Cancer; 1998 Apr; 77(7):1048-51. PubMed ID: 9569038 [TBL] [Abstract][Full Text] [Related]
2. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites. Manning AP; Mes-Masson AM; Seymour RJ; Tetrault M; Provencher DM; Tonin PN Mol Carcinog; 1999 Mar; 24(3):218-25. PubMed ID: 10204806 [TBL] [Abstract][Full Text] [Related]
3. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
4. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Mao L; Fan YH; Lotan R; Hong WK Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845 [TBL] [Abstract][Full Text] [Related]
6. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas. Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665 [TBL] [Abstract][Full Text] [Related]
8. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas]. Hong FZ; Wang B; Li HM; Liew CT Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544 [TBL] [Abstract][Full Text] [Related]
10. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Hendricks DT; Taylor R; Reed M; Birrer MJ Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
12. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related]
13. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101 [TBL] [Abstract][Full Text] [Related]
14. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related]
15. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma. Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284 [TBL] [Abstract][Full Text] [Related]
17. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas. Ferrer M; López-Borges S; Lazo PA Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816 [TBL] [Abstract][Full Text] [Related]
19. FHIT gene abnormalities in both benign and malignant thyroid tumours. Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301 [TBL] [Abstract][Full Text] [Related]
20. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]